Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site

Summary

The main objective of this study is to observe whether basic fibroblast growth factor and Kangfuxin Liquid can promote the wound healing in the donor area and further evaluate the healing quality.

Conditions

• Fibroblast Growth Factors
• Wound Healing

Interventions

DRUG

basic fibroblast growth factor

Basic fibroblast growth factor,100ml/ bottle, (35000IU / 8ml) / 100cm2 / time,three times a day.

DRUG

Kangfuxin Liquid

Kangfuxin Liquid,20ml / 100cm2 / time,three times a day.

DRUG

0.9% Normal saline

0.9% Normal saline,20ml / 100cm2 / time,three times a day.

Sponsors & Collaborators

• The Second Affiliated Hospital of Kunming Medical University

  collaborator OTHER

• Jiangyin Hospital Affiliated to Southeast University School of Medicine

  collaborator UNKNOWN

• Nantong University

  collaborator OTHER

• The 59th Central Hospital of the Chinese people's Liberation Army

  collaborator UNKNOWN

• Taizhou Hospital

  collaborator OTHER

• Zhejiang Quhua Hospital

  collaborator OTHER

• Lishui Country People's Hospital

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  lead OTHER

Principal Investigators

• huawei shao, MD · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

20 Years

Max Age

50 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-08-01

Primary Completion

2022-06-30

Completion

2022-12-31

Countries

• China

Study Locations